Cooley LLP is widely recognised for its expertise in executive compensation and employee benefits, advising companies at every stage of their lifecycle. The firm plays a critical role in high-stakes M&A, IPOs, SPAC transactions, and other corporate transitions, ensuring that compensation structures align with strategic business objectives. Led by Barbara Mirza in Los Angeles and Alessandra Murata in Palo Alto, and a team of top-tier attorneys, the practice is known for its ability to navigate complex compensation matters across industries, particularly in technology, life sciences, and artificial intelligence. With a strong presence in key innovation hubs, the firm combines deep industry knowledge with a pragmatic, business-focused approach, positioning itself as a go-to advisor for high-growth companies and market-leading public corporations.
Legal 500 Editorial commentary
- Profile
Key clients
- Rubrik
- Gracell Biotechnologies
- RayzeBio
- ProfoundBio
- Everbridge
- Carmot Therapeutics
- TempusAI
- PetIQ
- Alto Neuroscience
- Snowflake
Work highlights
- Advised Rubrik, the first cybersecurity vendor to successfully complete an IPO in over two years, a Zero Trust Data Security Company delivering data security and operational resilience for enterprises, priced at $752 million.
- Advised AuditBoard, a leading connected risk platform transforming audit, risk, compliance, and environmental, social and governance (ESG) management, on the benefits aspects of its agreement to be acquired for more than $3 billion by Hg.
- Advised Amolyt Pharma, a global clinical-stage biopharmaceutical company based in Lyon, France, which specializes in developing therapeutic peptides for rare endocrine and related diseases, on the compensation and benefits aspects of its acquisition by AstraZeneca for up to $1.05 billion in cash.
Lawyers
Practice head
Barbara Mirza, Alessandra Murata
Other key lawyers
Blake Martell; Nyron J. Persaud; Austin Holt